InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2024-02-02 00:00:00 ET · period of report 2024-01-31 · accession 0001209191-24-002721 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-02 2024-01-31 HCA Cuffe Michael S. EVP, Chief Clinical Off G - Gift $0.00 -728 28.1K -3% $0
D 2024-02-02 2024-01-31 HCA Cuffe Michael S. EVP, Chief Clinical Off S - Sale $306.79 -3,200 24.9K -11% -$981.7K
D 2024-02-02 2024-01-31 HCA Cuffe Michael S. EVP, Chief Clinical Off A - Grant $0.00 +12.7K 12.7K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-31 G D 728 $0.00 28,128.97 D — — (F1) Includes 2,436.9672 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
2 Common Common Stock 2024-01-31 S D 3,200 $306.79 24,928.97 D — — (F1) Includes 2,436.9672 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
3 Derivative Stock Appreciation Right 2024-01-31 A A 12,656 $0.00 12,656 D $304.90 · 2025-01-31 to 2034-01-31 12,656 Common Stock (F2) The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.